Published November 4, 2026 · Reporting window October 25–31, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.
9 articles and reminders, grouped by category.
No articles match this topic.
DOJ reports that a California physician received a 15-year sentence after convictions in a Medicare Botox billing scheme. The court ordered restitution and forfeiture, with restitution collection and net recovery not established in the announcement.
High priority · Nov 4, 2026 editionRead story →
On October 28, DOJ announced the arrest of a Virginia mental-health provider executive charged in connection with Medicaid crisis-services billing. DOJ alleges more than $49 million in false claims were submitted from January 2022 through April 2026, and describes alleged discrepancies between documented and actual staffing, falsified signatures and inducements. The indictment was returned October 20; the charges are allegations, and the defendant is presumed innocent unless proven guilty.
Medium priority · Nov 4, 2026 editionRead story →
On October 30, DOJ announced charges in three Minnesota Medicaid fraud matters. It reported an October 29 information against Habiba Mohamed in an alleged $19.1 million scheme, and October 28 indictments against Faiza Osman Ahmed involving an alleged $10 million scheme and Jama Yusuf Mohamod involving approximately $3.2 million in allegedly fraudulent claims. Charges are allegations and the defendants are presumed innocent.
Medium priority · Nov 4, 2026 editionRead story →
On October 27, a federal court sentenced Artem Stryzhak to 70 months in prison for his role in Hive ransomware activity, DOJ reported. DOJ attributed roughly 1,500 victims to the wider conspiracy and seven victims to Stryzhak and co-conspirators. DOJ described a hospital disruption in its account of the wider group; it did not identify that hospital as one of the seven.
Medium priority · Nov 4, 2026 editionRead story →
In an October 27, 2026 decision, an HHS administrative law judge affirmed CMS’s authority to revoke Glencare’s Medicare enrollment and place it on the preclusion list, based on the billing findings described in the decision. The contractor’s original notice was issued in August 2024, and the revocation took effect in September 2024. The judge said the length of the ten-year reenrollment bar was outside the judge’s review authority.
Medium priority · Nov 4, 2026 editionRead story →
On October 27, DOJ announced an ADA settlement following a complaint concerning communication with a deaf patient at a Lexington, Kentucky dialysis facility. DOJ said its investigation substantiated the complaint and that DaVita cooperated. The agreement says DaVita denies the allegations and is not admitting liability. DOJ describes updates to communication policies and practices, staff training and complaint reporting. The agreement describes measures for defined Kentucky facilities and provides for compensation and a civil penalty, subject to its conditions; it does not establish that those amounts have been paid.
Medium priority · Nov 4, 2026 editionRead story →
In an October 27, 2026 decision, an HHS administrative law judge affirmed the earlier revocation of Monasak’s DMEPOS enrollment after its insurance and accreditation lapsed. The decision found no evidence that the supplier had submitted a written voluntary termination before it became noncompliant. The earlier notice included a one-year reenrollment bar; the decision does not establish its current status.
Medium priority · Nov 4, 2026 editionRead story →
A DOJ victim-notification page marked updated October 27 reports that Swapnadip Roy’s status conference, previously scheduled for October 13, was continued to December 8, 2026, and his November 2 trial was continued to the January 2027 trial calendar. DOJ does not state when the continuance orders were entered. Roy and Vicky Ramancha face charges in the counterfeit Ozempic case; those charges are allegations and the defendants are presumed innocent.
Medium priority · Nov 4, 2026 editionRead story →
DOJ reports that Syed Murtuza Kablazada pleaded guilty to two health-care fraud counts involving Medicare claims for COVID-19 test kits that were not requested or provided. DOJ says the laboratories submitted $227 million in claims, of which Medicare paid approximately $136 million. DOJ also says Kablazada agreed to forfeit more than $46 million seized from bank accounts. Claims, payments and agreed forfeiture are distinct amounts; the release does not establish a sentence or completed recovery.
Medium priority · Nov 4, 2026 editionRead story →